lumbar degenerative disease
Conditions
Interventions
Erector spinae plane block group:Perform C-arm guided descending ropivacaine erector spinae plane block
Local infiltration analgesia group:Perform local infiltration analgesia at the incision site
Erector spinae plane block combined with local infiltration analgesia group:Perform C-arm guided descending ropivacaine erector spinae plane block and local infiltration analgesia at the incision site
Sponsors
The Second Hospital of Shanxi Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosed as lumbar disc herniation, lumbar spinal stenosis, or degenerative lumbar spondylolisthesis; 2. Perform posterior lumbar fusion surgery; 3. Voluntarily participate in clinical trials and sign informed consent forms.
Exclusion criteria
Exclusion criteria: 1. Combined with other spinal diseases such as tuberculosis, tumors, infections, fractures, metabolic bone diseases, etc; 2. History of posterior lumbar surgery; 3. Abnormal mental behavior; 4. Serious cardiovascular and cerebrovascular diseases, respiratory system diseases, renal dysfunction, and liver dysfunction; 5. Allergic to ropivacaine medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scores at 8 time points after surgery (Postoperative 0, 4, 8, 12, 24, 48, 72 hours, and 3 months);Intraoperative remifentanil dosage;Intraoperative sufentanil dosage;Effective number of presses of postoperative analgesia pump;Postoperative salvage analgesia rate;Total usage of postoperative opioid drugs;Postoperative hospitalization time;First active exercise time in bed;First time of getting out of bed activity;Patient satisfaction rating;Incidence of complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative dose of propofol;Intraoperative dosage of cisatracurium besylate; | — |
Countries
China
Contacts
Public ContactLu Li
The Second Hospital of Shanxi Medical University
Outcome results
None listed